SCHEMBL1119505

SCHEMBL1119505

CC(C)(C)N1CCCC(Nc2ccc([N+](=O)[O-])c(N)n2)C1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CDK2 P24941 1/20 0.34
▸ KMT2A Q03164 7/20 0.34
▸ MEN1 O00255 6/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ GSK3A P49840 2/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ BLM P54132 2/20 0.33
▸ ATM Q13315 2/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TXNRD1 Q16881 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1120246 0.82 PARP1 (0.44) MAPTMAPK1LMNAALDH1A1
SCHEMBL1514207 0.81 GFER (0.38) JAK3KMT2AMEN1GSK3AGSK3B
SCHEMBL1514204 0.81 GFER (0.38) JAK3KMT2AMEN1GSK3AGSK3B
SCHEMBL30533346 0.77 ALDH1A1 (0.44) MAPTMAPK1CDK2MAP4K4LMNA
SCHEMBL30533311 0.77 ALDH1A1 (0.44) MAPTMAPK1CDK2MAP4K4LMNA
SCHEMBL25411503 0.76 BTK (0.40) JAK3MAPK1MAP4K4SMN1; SMN2TXNRD1
SCHEMBL25407450 0.76 BTK (0.40) JAK3MAPK1MAP4K4SMN1; SMN2TXNRD1
SCHEMBL15573874 0.75 MAPK1 (0.52) MAPTMAPK1KMT2AMEN1NPSR1
SCHEMBL15985109 0.74 ALDH1A1 (0.51) MAPTMAPK1CDK2MAP4K4LMNA
SCHEMBL2935696 0.74 KCNH2 (0.41) CDK2KMT2AMEN1MAP4K4CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280976-A1 SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AS GSK3BETA-INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2011-02-09 — — EP disclosed
EP-2229392-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE AS GSK3BETA INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2010-09-22 — — EP disclosed
EP-2176264-A1 IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE Bayer Schering Pharma AG (DE) 2010-04-21 — — EP disclosed
WO-2009138176-A1 SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AS GSK3BETA-INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-11-19 — — WO disclosed
WO-2009074259-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-06-18 — — WO disclosed
WO-2009007029-A1 IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-01-15 — — WO disclosed
Send feedback